ascopubs.org6d
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States
LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations Among 187 patients identified (median follow-up, 22.4 ...
ascopubs.org6d
Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and Progress
Cancer remains one of the leading causes of morbidity and mortality worldwide. It is estimated that 19.3 million new cancer cases and nearly 10 million cancer-related deaths were reported in 2020 ...
ascopubs.org6d
Automated Identification of Breast Cancer Relapse in Computed Tomography Reports Using Natural Language Processing
Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models We analyzed follow-up CT reports from patients diagnosed with breast cancer ...
ascopubs.org7d
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia Indications for and implications of germline ...
ascopubs.org6d
Erratum: Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma ...
ascopubs.org7d
Safety and Efficacy of Antiangiogenesis Agents in Patients With Squamous Cell Carcinoma of the Lung: Time to Revise Outdated Constraints
Squamous cell carcinoma of the lung (LUSC) stands as the second most prevalent form of non–small cell lung cancer (NSCLC), constituting 20%-30% of patients with ...
ascopubs.org7d
It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management
CAMONCO 2: Results From a Randomized Controlled Trial Comparing Open Dialogue About Complementary Alternative Medicine and Standard Care on Patients' Quality of Life When incorporating this paper ...
ascopubs.org6d
Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing Administration
Teclistamab is initiated with a step-up dosing (SUD) schedule to mitigate the risk of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). Early ...
ascopubs.org6d
Implementation Strategy for Artificial Intelligence in Radiotherapy: Can Implementation Science Help?
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Artificial intelligence (AI) ...
ascopubs.org7d
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma In this trial, patients with recurrent ...
ascopubs.org6d
Prospective Observational Study on Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer in Rwanda: Acute Toxicity in Patients
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico Moderate hypofractionation (MHF) offers ...